Compare
Hims & Hers Health vs Labcorp (HIMS vs LH)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Hims & Hers Health (HIMS) returned -40.5% and Labcorp (LH) +46.2%; so far this year the figures are -19.9% and +46.1%.
Labcorp is the larger company by market value, about 4.9 times the size of Hims & Hers Health.
Revenue grew +28.0% at HIMS and +6.0% at LH over the last year.
HIMS pays no dividend. LH yields 0.79%.
Data as of the latest close. Not investment advice.
Relative performance
| HIMS | LH | |
|---|---|---|
| Price | $26.00 | $366.57 |
| 1-day | +8.06% | +0.90% |
| YTD | -19.93% | +46.11% |
| 1 year | -40.54% | +46.22% |
| 3 years | +341.43% | +79.74% |
| Market cap | $6.0B | $29.8B |
| P/E | — | 30.1 |
| P/S | 2.34 | 2.04 |
| P/B | 18.59 | 3.36 |
| Revenue growth | +28.00% | +6.00% |
| EPS growth | -179.70% | +19.60% |
| Gross margin % | 68.4 | 29.0 |
| Net margin % | -5.5 | 6.9 |
| ROE % | -43.8 | 11.3 |
| Debt / equity | 0.00 | 0.66 |
| FCF yield % | 1.0 | 4.3 |
| Dividend yield % | — | 0.79 |
| Beta | 2.74 | 0.38 |
| RSI (14) | 43.8 | 69.9 |
| Technical rating |